Pain therapeutics from cone snail venoms: From Ziconotide to novel non-opioid pathways.
Ontology highlight
ABSTRACT: There have been numerous attempts to develop non-opioid drugs for severe pain, but the vast majority of these efforts have failed. A notable exception is Ziconotide (Prialt®), approved by the FDA in 2004. In this review, we summarize the present status of Ziconotide as a therapeutic drug and introduce a wider framework: the potential of venom peptides from cone snails as a resource providing a continuous pipeline for the discovery of non-opioid pain therapeutics. An auxiliary theme that we hope to develop is that these venoms, already a validated starting point for non-opioid drug leads, should also provide an opportunity for identifying novel molecular targets for future pain drugs. This review comprises several sections: the first focuses on Ziconotide as a therapeutic (including a histo
SUBMITTER: Safavi-Hemami H
PROVIDER: S-EPMC6214764 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA